Refining a Digital Therapeutic Platform for Home Care Agencies in Dementia Care to Elicit Stakeholder Feedback: Focus Group Study With Stakeholders.

Autor:	Gilson A; Social & Administrative Pharmacy Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, United States., Gassman M; Social & Administrative Pharmacy Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, United States., Dodds D; Generation Connect, York, PA, United States., Lombardo R; Generation Connect, York, PA, United States., Ford Ii JH; Social & Administrative Pharmacy Division, School of Pharmacy, University of Wisconsin-Madison, Madison, WI, United States., Potteiger M; Generation Connect, York, PA, United States.
Jazyk:	angličtina
Zdroj:	JMIR aging [JMIR Aging] 2022 Mar 02; Vol. 5 (1), pp. e32516. Date of Electronic Publication: 2022 Mar 02.
DOI:	10.2196/32516
Abstrakt:	Background: Persons living with dementia require increasing levels of care, and the care model has evolved. The Centers for Medicare and Medicaid Services is transitioning long-term care services from institutional care to home- or community-based services, including reimbursement for nonclinical services. Although home care companies are positioned to handle this transition, they need innovative solutions to address the special challenges posed by caring for persons living with dementia. To live at home longer, these persons require support from formal caregivers (FCGs; ie, paid professionals), who often lack knowledge of their personal histories and have high turnover, or informal caregivers (eg, family or friends), who may have difficulty coping with behavioral and psychological symptoms of dementia. The Generation Connect platform was developed to support these individuals and their formal and informal caregivers. In preliminary studies, the platform improved mood and influenced caregiver satisfaction. To enhance platform effectiveness, Generation Connect received a grant from the National Institutes of Health Small Business Innovation Research to improve clinical outcomes, reduce health care costs, and lower out-of-pocket costs for persons living with dementia who receive care through home care agencies. Objective: This study aims to evaluate information elicited from a series of stakeholder focus groups to understand existing processes, needs, barriers, and goals for the use of the Generation Connect platform by home care agencies and formal and informal caregivers. Methods: A series of focus groups were conducted with home care agency corporate leadership, home care agency franchise owners, home care agency FCGs, and informal caregivers of persons living with dementia. The qualitative approach allowed for unrestricted idea generation that best informed the platform development to enable home care providers to differentiate their dementia care services, involve informal caregivers, improve FCG well-being, and extend the ability of persons living with dementia to age in place. Using the Technology-Enabled Caregiving in the Home framework, an inductive and iterative content analysis was conducted to identify thematic categories from the transcripts. Results: Overall, 39 participants participated across the 6 stakeholder focus groups. The following five overarching themes were identified: technology related; care services; data, documentation, and outcomes; cost, finance, and resources; and resources for caregivers. Within each theme, the most frequent subthemes were identified. Exemplar stakeholder group statements provided support for each of the identified themes. Conclusions: The focus group results will inform the further development of the Generation Connect platform to reduce the burden of caregiving for persons living with dementia, evaluate changes in cognition, preserve functional independence, and promote caregiver engagement between these individuals. The next step is to evaluate the effectiveness of the revised platform in the National Institutes of Health Small Business Innovation Research phase 2 clinical trial to assess the efficacy of its evidence-based interventions and market viability. (©Aaron Gilson, Michele Gassman, Debby Dodds, Robin Lombardo, James H Ford II, Michael Potteiger. Originally published in JMIR Aging (https://aging.jmir.org), 02.03.2022.)
Databáze:	MEDLINE
Externí odkaz:	Zobrazit plný text záznamu